Second Sight ’s Argus II Retinal Prosthesis Implanted in First Patient in Asia

--Underscores Second Sight’s Commitment to Expansion in Asia--
SYLMAR, Calif. --  Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful vision to blind patients, today announced that the Argus® II Retinal Prosthesis System ("Argus II") has been implanted in the first patient in Asia through an exclusive distribution partnership with Orient Europharma Co., Ltd. (OEP) and with charitable support from the Hong-Lu Foundation in Taiwan. The Argus II was provided under special import permits authorized by the Taiwan Food and Drug Administration (TFDA).
Read more: Second Sight Medical Products ( EYES )

Mazor Robotics Receives FDA Clearance for Spinal Deformity Correction Planning Software for the Mazor X Surgical Assurance Platform

CAESAREA, Israel -- Mazor Robotics Ltd. (TASE: MZOR)(NASDAQGM: MZOR), a pioneer and leader in the field of surgical guidance systems, has received FDA clearance for its Mazor X Align™ software. Mazor X Align is designed to assist surgeons in planning spinal deformity correction and spinal alignment for procedures performed with the Mazor X Surgical Assurance Platform. The new software will be demonstrated during exhibit hours at the 2017 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles, CA, April 22-26.
Mazor X Align leverages Mazor Robotics’ extensive experience in pre-operative planning, image processing, computerized anatomy recognition, and registration of different imaging modalities. It is the latest module to be added to the Mazor X proprietary Pre-operative Analytics software suite, and enables surgeons to create a patient-specific, three-dimensional spinal alignment plan. The 3D plan simulates an entire spine, allowing pre-operative estimation of the impact of a planned surgical correction on the patient’s posture post-operatively, considering segmental range-of-motion and final alignment parameters.
Read more: Mazor Robotics Ltd ( MZOR )

GeneNews Announces Contract with Large Multi-Specialty Physician Group For Use of Early Cancer Diagnostic Tests

Medical Group will be first in U.S. to offer BreastSentry® diagnostic test
TORONTO, March 16, 2017  - GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") announced today that it has signed an agreement with a large, multi-specialty physician group in the American Midwest for use of its cancer diagnostic tests. The contract represents the second partnership agreement with a U.S. healthcare services group and will mark the introduction of GeneNews' BreastSentry® diagnostic test to the U.S. market.
Read more: GeneNews Limited ( GEN )

Sunshine Heart Provides Business Update Regarding Execution of Strategic Growth Plan

EDEN PRAIRIE, Minn., March 23, 2017 -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today its progress in successfully executing its Aquadex growth strategy. After acquiring the Aquadex business from Baxter International in August of 2016, the company began executing a revenue growth strategy focused on increasing utilization in the top 55 hospital accounts, which made up 80% of the business. By the end of 2016, there were 95 hospital accounts that have re-engaged and are purchasing the disposable blood sets on a regular basis. As of March 2017, there are now 115 active hospital accounts.
“Our momentum is increasing as we reach more hospital accounts that have been quiet over the past few years,” said John Erb, Chairman of the Board and CEO of Sunshine Heart.
Read more: Sunshine Heart Inc ( SSH )

Corindus Announces Partnership with WakeMed Health & Hospitals

Leading cardiovascular hospital to develop vascular robotics program, improve patient care using the CorPath® GRX System
Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS) today announced that WakeMed Health & Hospitals will partner with Corindus to develop a national center of excellence to advance patient care and clinical robotics research and to train interventional cardiologists on robotic-assisted percutaneous coronary interventions ("PCI") using the CorPath GRX System. WakeMed Health & Hospitals is the leading provider of health and cardiovascular services in Wake County, North Carolina.
Read more: Corindus Vascular Robotics ( CVRS )

Videos / Webinars

View all videos

Pepperstone | Metatrader 4 Forex Broker